Carlos Carracedo Uribe, MD

Hematology & Oncology
Headshot of Carlos Carracedo Uribe
Headshot of Carlos Carracedo Uribe
Locations

Memorial Division of Hematology & Oncology

1150 North 35th Avenue
Suite 330
Hollywood, FL 33021

Phone: 954-265-4325

Fax: 954-981-3872

Get Directions

Memorial Division of Breast Medical Oncology

1150 North 35th Avenue
Suite 170
Hollywood, FL 33021

Phone: 954-265-4325

Fax: 954-965-6388

Get Directions

About Me

I am a board-certified, fellowship-trained medical oncologist at Memorial Healthcare System, where I treat patients with a range of oncology and hematology concerns. I diagnose and stage tumors, coordinate treatments with other specialists and provide ongoing follow-up care.

From a young age, I had the opportunity to witness the profound impact that compassionate and dedicated medical care can have on patients and their families. My parents are both physicians, and watching them build trusting relationships with their patients inspired me to enter the medical field.

I’ve always been driven by a desire to help others. Oncology has allowed me to combine that passion with a lifelong commitment to learning, problem-solving and advocating for my patients. It’s a privilege to guide patients and their families through some of the most challenging moments of their lives.

My approach to care is centered on compassion, communication and evidence-based medicine. I believe every patient deserves to be treated as a person, not just a diagnosis. That’s why I take the time to listen to my patients and build a relationship based on trust.

I strive to understand each patient’s concerns, explain diagnoses and treatment options and empower patients and their families to be active participants in their care.

Languages

  • Spanish

Areas of Focus

  • Tumor diagnosis and staging: Uses a range of blood tests, tissue biopsies and imaging techniques to diagnose and stage solid tumors and noncancerous blood conditions
  • Cancer treatment coordination: Collaborates with other specialists, such as surgical and radiation oncologists, radiologists and pathologists, to deliver and manage personalized cancer treatments
  • Long-term monitoring: Provides long-term follow-up care after completion of cancer treatment to watch for ongoing side effects and monitor continued remission

Education

Fellowships

  • Memorial Healthcare System Hematology and Medical Oncology Fellowship Program, 2026, Oncology and Hematology

Residency

  • Memorial Healthcare System, 2023, Internal Medicine

Medical Education

  • Universidad San Martin de Porres, 2017

Certifications

  • American Board of Internal Medicine-Internal Medicine
  • American Board of Internal Medicine-Medical Oncology

Awards Achievements and More

Publications

  • Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLG). Expert Review of Anticancer Therapy. 2025
  • Pancreatic adverse events in patients treated with immune checkpoint inhibitors. JGH Open. 2023
  • Importance of ROS1 gene fusions in non-small cell lung cancer. Cancer Drug Resistance. 2023
  • Acquired EGFR-resistance mutations in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 2022
  • EGFR L718V (+)/T790M (–) as a mechanism of resistance in patients with metastatic non-small cell lung cancer with EGFR L858R mutations. Clinical Lung Cancer. 2021

Professional Organizations

  • American Society of Clinical Oncology
  • American Society of Hematology